pqq cofactor has been researched along with Cardiac Hypertrophy in 2 studies
PQQ Cofactor: A pyrrolo-quinoline having two adjacent keto-groups at the 4 and 5 positions and three acidic carboxyl groups. It is a coenzyme of some DEHYDROGENASES.
pyrroloquinoline quinone : A pyrroloquinoline having oxo groups at the 4- and 5-positions and carboxy groups at the 2-, 7- and 9-positions.
Cardiac Hypertrophy: Enlargement of the HEART due to chamber HYPERTROPHY, an increase in wall thickness without an increase in the number of cells (MYOCYTES, CARDIAC). It is the result of increase in myocyte size, mitochondrial and myofibrillar mass, as well as changes in extracellular matrix.
| Excerpt | Relevance | Reference |
|---|---|---|
| " However, the therapeutic potential of PQQ for isoproterenol hydrochloride (Iso)‑induced cardiac hypertrophy has not yet been explored, at least to the best of our knowledge." | 7.96 | Pyrroloquinoline quinone attenuates isoproterenol hydrochloride‑induced cardiac hypertrophy in AC16 cells by inhibiting the NF‑κB signaling pathway. ( Dai, Z; Jin, Y; Shen, J; Wen, J; Zhao, X; Zhou, Y, 2020) |
| " However, the therapeutic potential of PQQ for isoproterenol hydrochloride (Iso)‑induced cardiac hypertrophy has not yet been explored, at least to the best of our knowledge." | 3.96 | Pyrroloquinoline quinone attenuates isoproterenol hydrochloride‑induced cardiac hypertrophy in AC16 cells by inhibiting the NF‑κB signaling pathway. ( Dai, Z; Jin, Y; Shen, J; Wen, J; Zhao, X; Zhou, Y, 2020) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 2 (100.00) | 2.80 |
| Authors | Studies |
|---|---|
| Qu, XF | 1 |
| Zhai, BZ | 1 |
| Hu, WL | 1 |
| Lou, MH | 1 |
| Chen, YH | 1 |
| Liu, YF | 1 |
| Chen, JG | 1 |
| Mei, S | 1 |
| You, ZQ | 1 |
| Liu, Z | 1 |
| Zhang, LJ | 1 |
| Zhang, YH | 1 |
| Wang, Y | 1 |
| Wen, J | 1 |
| Shen, J | 1 |
| Zhou, Y | 1 |
| Zhao, X | 1 |
| Dai, Z | 1 |
| Jin, Y | 1 |
2 other studies available for pqq cofactor and Cardiac Hypertrophy
| Article | Year |
|---|---|
Pyrroloquinoline quinone ameliorates diabetic cardiomyopathy by inhibiting the pyroptosis signaling pathway in C57BL/6 mice and AC16 cells.
Topics: Animals; Cardiomegaly; Diabetes Mellitus, Experimental; Diabetic Cardiomyopathies; Fibrosis; Glucose | 2022 |
Pyrroloquinoline quinone attenuates isoproterenol hydrochloride‑induced cardiac hypertrophy in AC16 cells by inhibiting the NF‑κB signaling pathway.
Topics: Cardiomegaly; Cell Line; Humans; Isoproterenol; Myocytes, Cardiac; NF-kappa B; PQQ Cofactor; Signal | 2020 |